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Within the last two decades, the incidence of invasive fungal infections has been
significantly increased. They are characterized by high mortality rates and are often
caused by Candida albicans and Aspergillus fumigatus. The increasing number of
infections underlines the necessity for additional anti-fungal therapies, which require
extended knowledge of gene regulations during fungal infection. MicroRNAs are
regulators of important cellular processes, including the immune response. By analyzing
their regulation and impact on target genes, novel therapeutic and diagnostic approaches
may be developed. Here, we examine the role of microRNAs in human dendritic cells
during fungal infection. Dendritic cells represent the bridge between the innate and the
adaptive immune systems. Therefore, analysis of gene regulation of dendritic cells is
of particular significance. By applying next-generation sequencing of small RNAs, we
quantify microRNA expression in monocyte-derived dendritic cells after 6 and 12 h of
infection with C. albicans and A. fumigatus as well as treatment with lipopolysaccharides
(LPS). We identified 26 microRNAs that are differentially regulated after infection by
the fungi or LPS. Three and five of them are specific for fungal infections after 6 and
12 h, respectively. We further validated interactions of miR-132-5p and miR-212-5p with
immunological relevant target genes, such as FKBP1B, KLF4, and SPN, on both RNA
and protein level. Our results indicate that these microRNAs fine-tune the expression
of immune-related target genes during fungal infection. Beyond that, we identified
previously undiscovered microRNAs. We validated three novel microRNAs via qRT-PCR.
A comparison with knownmicroRNAs revealed possible relations with the miR-378 family
and miR-1260a/b for two of them, while the third one features a unique sequence with no
resemblance to known microRNAs. In summary, this study analyzes the effect of known
microRNAs in dendritic cells during fungal infections and proposes novel microRNAs that
could be experimentally verified.
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1. INTRODUCTION
Due to their increasing number, invasive fungal infections are
gaining growing importance and the medical community has
placed increased emphasis on their impact in public health
(Richardson and Lass-Flörl, 2008). Reasons for rising incidences
are an increasing number of immunocompromised patients due
to transplantations, cancer, and HIV infections (Richardson,
2005; Richardson and Lass-Flörl, 2008). It is estimated that
the amount of life-threatening infections by opportunistic fungi
exceeds 2,000,000 per year worldwide (Brown et al., 2012).
These high numbers are accompanied by a high morbidity
of patients and mortality rates of more than 40% in severely
immunocompromised patients, such as allogeneic stem cell
transplant recipients and patients with acute leukemia, suffering
from invasive aspergillosis (Pfaller and Diekema, 2007; Brown
et al., 2012; Montagna et al., 2013). Invasive candidiasis, mostly
caused by Candida albicans, and invasive aspergillosis, mostly
caused by Aspergillus fumigatus, are the main types of invasive
fungal infections (Pagano et al., 2007; Pappas et al., 2010).
However, the regulatory response of the immune system to fungal
infections has not been completely understood yet.
MicroRNAs are short (≈ 22 nt) non-coding RNAs that
post-transcriptionally regulate the gene expression by RNA
silencing or RNA degradation. They originate from primary
transcripts (pri-microRNAs), which are processed into hairpin
structures (precursors, pre-microRNAs) by the Drosha enzyme.
After export from the nucleus into the cytoplasm, the pre-
microRNAs are then cleaved by the Dicer enzyme into short
duplexes of ≈ 22 nt length. One strand of the duplex forms the
microRNA-induced silencing complex (miRISC) together with
the Argonaute protein and several other proteins (Finnegan
and Pasquinelli, 2013). Guided by the microRNA, the miRISC
binds to a target mRNA in its 3′-UTR, thereby inducing
mRNA destabilization or translational repression (Chekulaeva
and Filipowicz, 2009). In a few cases, the binding can also
happen in the 5′-UTR or in the coding region (Moretti et al.,
2010).
MicroRNAs are involved in many physiological processes like
cell differentiation and organ development (Zhao and Srivastava,
2007) but also play crucial roles in the development and
functioning of the immune system (Carissimi et al., 2009; Xiao
and Rajewsky, 2009). They contribute to the regulation of the
immune system by influencing the function and differentiation
of various immune cells of both the innate and the adaptive
immune responses (Gracias and Katsikis, 2011). The innate
immune system, mainly neutrophilic granulocytes and resident
macrophages represent the first line of defense against invasive
fungal infections. Denditic cells (DCs) are key for the immune
defense against fungi as they build a bridge between the innate
and the adaptive immune system (Morton et al., 2011). These
antigen-presenting cells are involved in pathogen recognition
and are solely able to prime naïve T cells in the lymph nodes,
thereby determining the fate of the immune response (Wüthrich
et al., 2012). Thus, an extended understanding of the regulations
may give rise to new therapeutic approaches in anti-fungal
therapy.
In this study, we investigate in vitro the role of microRNAs
in response to fungal infections by C. albicans and A. fumigatus.
Thus, we contribute new knowledge to the role of microRNAs
in the response to fungal infections. In a previous study,
Monk et al. (2010) analyzed the regulation of microRNAs in
murine macrophages when encountering C. albicans. In contrast,
our study is directly based on human cells instead of model
organisms. Moreover, we apply next-generation sequencing of
small RNA instead of microRNA microarrays, which allows
studying microRNA expression at higher precision and depth
and enables the prediction of novel microRNAs (Pritchard et al.,
2012). Das Gupta et al. (2014) examined the expression of miR-
155 and miR-132 in human DCs and their in vitro precursors
using A. fumigatus and lipopolysaccharides (LPS) as stimuli.
In comparison, we are not limited to a previous selection of
microRNAs, as we use RNA-sequencing techniques. In this way,
we consider all known human microRNAs and thus we may get a
broader view on the regulatory mechanisms in DCs.
In conclusion, this study provides insights on the regulatory
role of microRNAs in DCs during fungal infections. Based on
differential expression and subsequent validation experiments,
we demonstrate the fine-tuning effect of selected microRNAs on
their immune-relevant targets. Additionally, we discovered and
validated novel microRNAs. Therefore, the results of this study
contribute to a more comprehensive understanding of the anti-
fungal immune response and thus may support the identification
of drug targets and the development of novel therapies.
2. MATERIALS AND METHODS
2.1. Aspergillus Culture
The fungal strain A. fumigatus ATCC 46645 (American Type
Culture Collection, LGC Standards) was used for all experiments.
Germ tubes were prepared as previously described (Mezger et al.,
2008) and inactivated by incubation in 100% Ethanol for 45min.
2.2. Candida Culture
Wild-type C. albicans SC5314 was maintained as previously
described (Leonhardt et al., 2015). For experiments, colonies
were transferred to M199 medium (PAA), pH 4 and cultured at
30◦C to stationary phase. Germ tubes were induced by culturing
in M199 medium, pH 8 for 1 h at 37◦C. Germ tubes were
inactivated by washing them in phosphate-buffered saline (PBS)
and followed by incubation in PBS containing 0.1% thimerosal
(Sigma-Aldrich) for 1 h at 37◦C with shaking. Afterwards, germ
tubes were washed five times and then re-suspended in RPMI-
1640. Killing was confirmed by plate counts on YPD (2% D-
glucose, 1% peptone, 5% yeast extract, Roth) agar plates.
2.3. Generation and Co-Culture of DCs
DCs were generated from PBMCs as previously described
(Mezger et al., 2008). Briefly, PBMCs were isolated from
completely independent healthy volunteers by ficoll (Bicoll
Seperation, Biochrom AG) density gradient centrifugation.
Magnetic activated cell sorting with paramagnetic CD14-beads
(Miltenyi Biotec) was used to further separate monocytes.
Monocyte-derived dendritic cells (DCs) were generated in
Frontiers in Microbiology | www.frontiersin.org 2 February 2017 | Volume 8 | Article 270
Dix et al. MicroRNAs during Fungal Infection
RPMI-1640 supplemented with 10% FBS (Sigma Aldrich), 120
mg/l Refobacin (Merck), 10 ng/ml IL-4 (Miltenyi Biotec) and 100
ng/ml GM-CSF (Bayer Healthcare) for 6 days.
Co-cultivation experiments of DCs with A. fumigatus or
C. albicanswere performed with amultiplicity of infection (MOI)
of 1 on day 6 for 6 h and 12 h. LPS (1µg/ml, Sigma Aldrich) was
used in the indicated concentration. Four independent biological
replica (no technical replica) were performed. Stimulation of DCs
was monitored by flow cytometry. Induction of the DC surface
markers CD83 and CD86 was significant for A. fumigatus, C.
albicans and LPS after 6 and 12 h, respectively. Induction of HLA-
DR was significant after 6 h (Data not shown). Furthermore,
quantification of secreted protein levels by multiplex ELISA
assays demonstrated activation as well.
2.4. MicroRNA Sequencing
MicroRNA sequencing was performed as previously described
(Steinhilber et al., 2015). Briefly, total RNA was isolated using the
miRNeasy Mini Kit (Qiagen, Hilden, Germany). RNA samples
had a RNA integrity number (RIN) of 8.9 ± 0.9 determined by
Agilent Bioanalyzer. 500 ng total RNA, determined by Nanodrop
1000 (Thermo Scientific), was used to generate small RNA
sequencing libraries by TruSeq Small RNA Library Prep Kit
(Illumina, San Diego, CA) according to the manufacturer’s
instructions. MicroRNA enriched fractions were isolated from E-
Gel (Invitrogen) and quantified by Qbit Instrument (Invitrogen).
Equimolare amounts were loaded on a GAIIx single read
flow cell (Illumina) and cBot instrument (Illumina) and the
TrueSeq Cluster Generation Kit (Illumina) was used to generate
clusters. A single 32 nt sequencing run was performed to obtain
microRNA sequences. In a next step, barcode sequences were
identified by a 7 nt sequencing run. Fastq files were obtained
by using CASAVA1.7 (Illumina) and the Fastq ASCII qualities
were transferred from Illumina v1.3 to Sanger scale with FastQ
Groomer (Cock et al., 2010). Linker sequences were removed
by fastx clipper (http://hannonlab.cshl.edu/fastx_toolkit/index.
html). The microRNA data has been deposited in the GEO NCBI
database (Edgar et al., 2002) (accession code GSE80014).
2.5. Short-Read Mapping and Counting
The sequenced reads were mapped to known microRNA
precursors, downloaded from miRBase (version 20) using the
tool “bowtie” Langmead et al. (2009) (version 0.12.9) with the
parameters -v 1 -a -p 1 –best –norc. Afterwards, only those reads
were counted which were aligned to the positions of the mature
microRNAs in the corresponding precursor sequences, allowing a
deviation of 2 nt upstream or downstream. If a read had multiple
hits, then the count of this read was divided by the number of
hits. In this way, we split the impact of a multiple-hit read and
avoid over- or underestimation of microRNAs with very similar
sequences. Finally, the counts were rounded to integer numbers.
Of the 2,578 mature microRNAs, those exhibiting raw counts
fewer than 10 in all samples were discarded to remove noise,
leaving 463 microRNAs for analysis. The counts were normalized
to “counts per million,” where the counts of each sample are
divided by the sum of all counts of each sample (i.e., the library
size) and are multiplied by one million.
2.6. mRNA Analysis
DCs of four independent donors were harvested after 6 and 12
h co-culture with A. fumigatus, C. albicans and LPS and analyzed
with Affymetrix whole genome expression arrays. RNA samples
had a RNA integrity number (RIN) above eight determined
by Agilent Bioanalyzer. RNA samples were hybridized to an
Affymetrix HG-U219 array plate. Scanned images were subjected
to visual inspection to control for hybridization artifacts and
proper grid alignment; these were analyzed with AGCC 3.0
(Affymetrix) to generate CEL files. The resulting files, containing
a single intensity value for each probe region delineated
by a grid on each array image, were imported into Partek
Genomics Suite (version 6.6, Partek, St. Louis, MO) for probe
set summarization and statistical analysis. Model based Robust
Multichip Analysis (Irizarry et al., 2003) was performed for probe
set summarization to obtain a single intensity value representing
transcript abundance for each probe set and thus enable
comparisons between arrays, by normalizing and logarithmically
transforming array data and stabilizing variance across the arrays.
Microarray data has been deposited in the GEO NCBI database
(Edgar et al., 2002) (accession codes GSE69723 and GSE77969).
2.7. Differentially Expression Analysis
Differentially expressed microRNAs (DEMs) were determined
using the R package “limma” (Smyth, 2005) (version 3.28.19).
Limma uses linear models and moderated t-statistics to detect
differential expression. It provides the “voom” function which
transforms sequencing data, so that linear modeling can be
applied (Law et al., 2014). The p-values were adjusted according
to the false discovery rate (FDR) (Benjamini and Hochberg,
1995). MicroRNAs exhibiting an adjusted p-value < 0.05 were
considered as differentially expressed.
To identify differentially expressed mRNAs in the microarray
data, also the R package “limma” was used. Those mRNAs
with both an FDR-adjusted p-value < 0.05 and an absolute
fold-change of at least two were considered as significantly
differentially expressed.
2.8. Target Genes Of The Fungal-Specific
MicroRNAs
Experimentally validated microRNA targets were obtained
from the database miRTarBase (Hsu et al., 2014) (release
4.5). miRTarBase contains microRNA-target-interactions (MTIs)
from manually curated literature search. The MTIs from
miRTarBase are categorized into functional and non-functional,
where each can be supported by strong or weak experimental
evidences. Reporter assays, western blots, and qPCRs are
regarded as strong support, while support by microarrays,
sequencing data, pSILAC, or other methods is considered as less
strong. To get the most reliable information, we filtered the target
genes to keep only the functional MTIs with strong support.
MicroRNA targets were further predicted with the tools
miRanda (Enright et al., 2003) (version 3.3a) and MirTarget2
(Wang and El Naqa, 2008; Wong and Wang, 2015). MiRanda
scans the 3′-UTR of mRNA sequences for possible binding sites
based on sequence complementarity and also calculates the free
energy of the binding. It was used with the parameters --strict to
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allow only strict seed pairing, and -en 20, which sets a threshold
for the free energy to −20 kcal/mol. Besides the microRNA
sequences, miRanda requires the 3′-UTR sequences as input.
They were downloaded from Ensembl Biomart (Kinsella et al.,
2011) (version 77), covering 18,749 genes.
MirTarget2 uses a support vector machine which was trained
with a broader range of features including sequence conservation,
the secondary structure of the target site, sequential properties of
both the microRNA and the target site, and the location of the
binding site within the 3′-UTR. The algorithmMirTarget2 is part
of the online resource miRDB (http://www.mirdb.org/), where
the microRNA sequences were submitted to receive predicted
target genes.
2.9. Validation of Predicted microRNA
Targets
All RNA interference experiments were performed as previously
described (Mezger et al., 2008). Briefly, DCs were electroporated
(EPI 2500, Dr. L. Fischer) with either short interfering
single-stranded RNA inhibiting miR-132-5p, miR-212-5p
or non-silencing, random RNA (ThermoFisher) at 340V for
10ms on day 5 after isolation and then incubated at 37◦C and 5%
CO2 for 24 h in culture medium. MicroRNA quantification was
performed after stimulation with either A. fumgiatus, C. albicans
or LPS, as previously described (Das Gupta et al., 2014). RNA
was isolated by using miRVana microRNA isolation kit (Thermo
Fisher Scientific) according to manufacturer’s instructions.
Specific cDNA was generated from 100 ng template. Subsequent
quantification of these specific microRNAs was performed
by quantitative real-time PCR (qPCR) with TaqMan probes
as described by the manufacturer (MicroRNA RT Kit and
microRNA-specific TaqMan MicroRNA Assays, both Thermo
Fisher Scientific). cDNA synthesis of mRNA was performed
with First Strand cDNA synthesis Kit (Thermo Fisher Scientific).
Quantitative real-time PCR was performed on a StepOne Plus
(Applied Biosystem) with iTaq Universal SBYR Green Supermix
(BioRad) and the primers for BTN3A2 (NM_001197248.2)
fw: ACAGAGCGGGAAATAAGCCT, rv: AACAAGGTGGAG
CCTCATCTG, FKBP1B (NM_004116.3) (AGATCGAGA
CCATCTCCCCC), rv: AAGCTCATCTGGGCTGCAC, KLF4
(NM_004235.4) fw: TACCAAGAGCTCATGCCACC, rv: CGC
GTAATCACAAGTGTGGG, SPN (NM_001030288.2): fw CTT
ATCAGCCGAGCCGGTCC, rv: GTGTCTGCACTGCTG
TTGTG, TRIM22 (NM_001199573.1) fw: AGATCTCCAGCG
GAGGTTGA, rv: AACTTGCAGCATCCCACTCA, IFITM2
(NM_006435.2) fw: ATCCCGGTAACCCGATCAC, rv: CTT
CCTGTCCCTAGACTTCAC, ALAS1 (NM_000688.5) fw: GGC
AGCACAGATGAATCAGA, rv: CCTCCATCGGTTTTCACA
CT (Sigma Aldrich) were used in a concentration of 0.5µM at a
total reaction volume of 20µl.
2.10. Western Blotting
Cells were re-suspended in lysis buffer (6.65M Urea (Sigma),
10% Glycerin, 1% SDS, 10mM Tris (Carl Roth GmbH), pH 6.8),
sonicated for 15 s (UP50H, Hielscher) and proteins quantified
using the DC Protein Assay (BioRad). Cell lysates were subjected
to sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to nitrocellulose membranes.
Membranes were incubated with rabbit anti-KLF4, anti-IFITM2
(Cell Signaling), goat anti-SPN and anti-FKBP1B (R&D systems)
and mouse anti-β-Actin (Sigma Aldrich) antibodies over night at
4◦C or for 2 h at room temperature, respectively. Horseradish-
conjugated anti-rabbit, anti-mouse (Cell Signaling) and anti-
goat (R&D systems) IgG antibodies were used as secondary
antibodies. Signals were visualized by ECL reaction with
ClarityTM ECL Western Substrate (BioRad) or PierceTM ECL
Western Blotting substrate (Thermo Scientific) and analyzed
using ImageJ software (ImageJ version 1.47, National Institutes
of Health).
2.11. Discovery of Novel microRNAs
Previously unknown microRNAs were discovered by using the
tool miRDeep2 (version 2.0.0.5) (Friedländer et al., 2012). The
mapper module of miRDeep2 was run with the parameters -d
-e -h -i -j -m -u -v to perform sequence preprocessing and to
map the reads to the human genome (hg19). For the miRDeep2
module, the input data were the precursor andmaturemicroRNA
sequences of Homo sapiens from miRBase, the mapping of
the mapper module, and the mature microRNA sequences of
the hominoids Gorilla gorilla, Pan paniscus, Pongo pygmaeus,
Pan troglodytes, and Symphalangus syndactylus as input from
related species. The latter are used by miRDeep2 to search for
seed sequence conservation, which is included into the scoring.
According to the recommendation of Friedländer et al. (2012),
we considered only the predictions with a signal-to-noise ratio of
10 or higher for further analysis. We further filtered the predicted
microRNAs using a randfold p-value of 0.05 as cutoff, which
suggests stable secondary structures, and kept only predictions
without a “Rfam alert,” which indicates that a rRNA or tRNA
was found instead of a microRNA. Subsequently, we defined
predictions as high-confidence, if the 3p as well as the 5p mature
microRNAwere found at least in two time points or two different
infections (A. fumigatus, C. albicans, or LPS). Overlapping high-
confidence predictions were resolved by keeping those with
the highest scores. Finally, the counts of the predicted mature
microRNAs were determined for each sample.
To identify sequence similarities between novel and known
microRNAs, we used the tool BLAST (version 2.2.31) with
the known human mature microRNAs from miRBase (version
20) and the validated novel microRNAs as input. For multiple
sequence alignment, ClustalW (Larkin et al., 2007) (version 2.1)
was used with default parameters. The phylogenetic tree was
plotted with TreeDyn (Chevenet et al., 2006) (version 198.3)
on the Phylogeny.fr server (Dereeper et al., 2008) using default
settings.
2.12. Validation of Predicted Novel
MicroRNAs
RNA extraction was performed using themiRNeasy Kit (Qiagen).
500 ng of RNA was applied to perform cDNA synthesis using
the miScript II RT Kit (Qiagen). qRT-PCR was performed on
a LightCycler480 System (Roche, Mannheim, Germany) using
the miScript SYBR Green PCR Kit (Qiagen) according to the
manufacturer’s instructions. Standard curves for each amplified
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FIGURE 1 | Venn diagrams of the differentially expressed microRNAs of the treatments with A. fumigatus, C. albicans, or LPS.
transcript were generated to obtain the PCR efficiency. CP-
values were determined by the LightCycler Software 480 (Roche).
Expression levels of each sample were detected in triplicate
reactions. RNU6B (content of the Hs_RNU6B_2miScript Primer
Assay, Qiagen) was used as reference gene. Relative expression
levels of each target microRNA were calculated applying
the efficiency-corrected equation by Pfaﬄ et al. (2002) using
qbase PLUS v2.4 (Biogazelle). For the detection of predicted
microRNAs oligonucleotides with the respective sequence of the
mature microRNA were used as forward primer. The universal
reverse primer was included in the miScript SYBR Green PCR
Kit. The sequences of the oligonucleotides are listed in the
Supplementary Table 1. Validation experiments were performed
on specimens from independent donors.
2.13. Ethics
This study, using whole blood specimens obtained from human
healthy volunteer donors, was approved by the Ethics Committee
of the University of Würzburg (approval 302/12). Data analysis
was conducted anonymously.
3. RESULTS
3.1. MicroRNA Signatures are Specific for
Fungal Infections
In order to study the expression of human microRNAs during
fungal infection, we analyzed next-generation sequencing data
of human dendritic cells (DCs) infected with A. fumigatus and
C. albicans germ tubes. To compare the expression of microRNAs
during fungal infection with bacterial infection, we simulated
bacterial infection by adding lipopolysaccharides (LPS) to DCs.
As a control for all infected DCs, we used mock infected samples.
Six hours post infection, we identified three, five, and five
differentially expressed microRNAs (DEMs) for A. fumigatus,
C. albicans, and LPS, respectively (Supplementary Table 2).
Twelve hours post infection 9, 10, and 20 DEMs were detected.
The vast majority of the DEMs were up-regulated, while
four microRNAs showed a down-regulation. Several DEMs are
overlapping between the conditions (A. fumigatus, C. albicans
germlings, and LPS) and the time points (6 and 12 h) (Figure 1).
We clustered the expression data of all 26 unique DEMs by
using multidimensional scaling (MDS), which is a dimension
reduction method and thus allows visualizing of similarities
between samples. The clustering is based on Spearman
correlations, which means that samples with high correlation
coefficients are close to each other in the plot. The MDS plot
(Figure 2) shows the grouping of the data. There is a separation
between fungal and LPS samples, while the samples of the
fungal species are mixed. Moreover, the 6 h samples of all three
conditions are closer to the control samples, indicating higher
similarities than the 12 h samples.
To select DEMs that are specific for the response to fungal
infections, we determined which DEMs were differentially
regulated for A. fumigatus and C. albicans together, but not for
LPS. In this way, we found three DEMs (miR-132-3p, miR-
132-5p, miR-212-5p) for the 6 h and five DEMs (miR-129-
5p, miR-132-3p, miR-132-5p, miR-212-3p, miR-212-5p) for the
12 h samples (Figure 1). While miR-132-3p has been linked to
A. fumigatus infections before (Das Gupta et al., 2014), it is also
involved in different immune processes together with miR-212-
3p (Wanet et al., 2012). In contrast, this is the first study which
identified miR-132-5p and miR-212-5p to play major roles in the
immune regulation. Besides that, the microRNA miR-129-5p has
been associated to different cancer types (Li et al., 2013; Yu et al.,
2013).
3.2. Fungal-Specific MicroRNAs Target
Immune Related Genes
As microRNAs play an important role in post-transcriptional
gene regulation, we analyzed their target genes. There are many
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FIGURE 2 | Multidimensional scaling (MDS) plot of the samples in this
study. The MDS is based on Spearman correlations, which means that similar
samples are close to each other, while different samples are distant. Colors
represent the treatment of a sample and the shapes the time point. Infection is
different to control and bacterial infection is different to fungal.
tools for predicting the microRNA targets, where each one
considers different features of the microRNA-target-interaction
(MTI). Therefore, we decided to use multiple sources to
cover a broader range of potential target genes. We used
the database miRTarBase to obtain a list of experimentally
validated MTIs. Additionally, we used miRanda and MirTarget2
to predict microRNA targets. With these three sources, we
determined target genes for the fungal-specific DEMs. While
the number of their validated MTIs is below twelve, the
prediction of target genes yielded several hundred candidates
(Table 1).
Since microRNA target prediction is a difficult task, which
often leads to a high number of false positives Hamzeiy et al.
(2014), it is important to filter for the most promising and
interesting candidates. As shown by Eichhorn et al. (2014),
mRNA destabilization is the main mode of repression by
microRNAs. Therefore, we can assume that during time course
of infection the expression of potential target genes is inversely
correlated to the expression of their microRNA regulators. In
accordance with this assumption, we used microarray data of
the same conditions and time points to determine which of
the target genes are significantly down-regulated, since all of
the fungal DEMs are up-regulated in both time points. In a
first filtering step, we kept only those target genes that show
down-regulation for A. fumigatus or C. albicans. The second
filtering step comprises a correlation analysis. We calculated
the Pearson correlation of the microRNA expression values and
the expression intensities of the filtered target genes across all
samples. Genes with a correlation coefficient of -0.5 or less were
retained as high-confidence targets. This correlation threshold
has been used successfully in previous microRNA studies (Fu
et al., 2012; Summerer et al., 2015). Applying both filters left
TABLE 1 | The number of target genes obtained from different resources.
microRNA miRTarBase miRanda MirRarget2
miR-132-3p 11 302 379
miR-132-5p 0 543 41
miR-129-5p 3 168 896
miR-212-3p 8 383 382
miR-212-5p 0 1857 325
While miRanda and MirTarget2 predict putative microRNA targets, miRTarBase provides
experimentally validated target genes.
TABLE 2 | Correlation coefficients between the expression of fungal DEMs
for 6 h and their high-confidence targets.
6 h
miR-132-3p miR-132-5p miR-212-5p
SAP30L −0.750 FKBP1B −0.866 KLF4 −0.832
ATP10D −0.881 DHTKD1 −0.801
ABCG1 −0.813 DNPEP −0.790
BARD1 −0.556 TRIM22 −0.531
TTC39C −0.859
19 unique target genes. Some of them are regulated by multiple
microRNAs (Tables 2, 3).
The resulting set of target genes includes genes playing a
role in immune response. For example, for miR-132-5p, these
genes are BTN3A2, which is associated to the stimulation of the
adaptive immune response in DCs Simone et al. (2010), and
FKBP1B that is associated to T cell proliferation in mice (Dubois
et al., 2003) and is connected to the response to viral infections
(Krishnan et al., 2008; Carbajo-Lozoya et al., 2012).
3.3. MicroRNAs Fine-Tune The Gene
Expression In Dendritic Cells
In order to confirm and analyze the predicted and filtered
microRNA targets, we selected multiple predicted MTIs for
validation via silencing of microRNA and qPCR analysis of
their potential target genes. We decided to concentrate on the
microRNAs miR-132-5p and miR-212-5p for two reasons: First,
only little is known about the roles of these two mircoRNAs in
the anti-fungal response. Second, both microRNAs have the most
immune-related target genes in their filtered lists (see above).
The immunological relevant targets of miR-212-5p are KLF4,
which has been shown to be involved in the response of DCs
to fungal infections (Czakai et al., 2016) and to be important for
inflammatory immune response (Alder et al., 2008; Rosenzweig
et al., 2013), and SPN, a surface molecule of various immune
related cells, e.g., T lymphocytes, thymocytes, monocytes, and
neutrophiles (Remold-O’Donnell et al., 1987). Moreover, both
TRIM22 and IFITM2 play a role in the anti-viral immune
response (Brass et al., 2009; Singh et al., 2011).
We silenced miR-132-5p and miR-212-5p in separate
experiments in DCs generated under identical conditions and
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TABLE 3 | Correlation coefficients between the expression of fungal DEMs for 12h and their high-confidence targets.
12 h
miR-132-3p miR-132-5p miR-129-5p miR-212-3p miR-212-5p
MTMR1 −0.788 BTN3A2 −0.663 FAM46A −0.545 SP110 −0.778 KLF4 −0.748
SP110 −0.799 FKBP1B −0.934 ADD3 −0.588 MTMR1 −0.863 DHTKD1 −0.865
TTC39C −0.773 CASP6 −0.606 DNPEP −0.828
CCDC170 −0.516 SPN −0.772
TRIM22 −0.690
IFITM2 −0.795
in accordance to the co-incubation settings using microRNA
inhibitors. The validation results (Figure 3) revealed that the
regulatory effects of the microRNAs are weaker than suggested
by the microarray data. However, an up-regulation of the
target genes (BTN3A2, FKBP1B, KLF4, SPN, TRIM22, and
IFITM2) is visible when the corresponding microRNAs are
silenced. Infections with C. albicans led to an increased up-
regulation compared to A. fumigatus infections for all target
genes. Additionally, for the genes BTN3A2, SPN, and TRIM22,
no up-regulation is visible for A. fumigatus infections with
silenced microRNAs in the qPCR experiments. Although the
expression differences between the silenced and the non-silenced
measurements are not statistically significant, a trend toward
increased expression intensities in case of microRNA silencing
can be found. We further analyzed the expression changes
of FKBP1B, KLF4, SPN, and IFITM2 on protein level by
performing western blot experiments. Similar to the qPCR
results, a trend toward up-regulation on microRNA silencing can
be found (Figure 4). In contrast to the qPCR data, the increase
of protein amount is higher for A. fumigatus infections than
for C. albicans infections, with the exception of IFITM2. The
validation experiments of both qPCR and western blot indicate
that the regulation by the microRNAs happens on a level of
fine-tuning.
3.4. Discovery of Novel MicroRNAs
Next-generation sequencing not only allows to study gene
expression with high accuracy, but also the identification of so
far unknown genes (Linde et al., 2015) as well as microRNAs
(Dannemann et al., 2012). To our knowledge, this is the first
study which performs next-generation sequencing of human
microRNAs during fungal infection. Therefore, we scanned the
RNA-Seq data for previously unknown microRNAs. We applied
the tool miRDeep2 (Friedländer et al., 2012) to the control and
the LPS samples, as well as to the fungal data comprising the
pooled data of both fungal species. The miRDeep2 algorithm
works in multiple stages. First, the reads of the microRNA
dataset are preprocessed (i.e., clipping of adapter sequence and
collapsing identical reads) and mapped to the genome. Next,
the algorithm excises potential microRNA precursors from the
genome, which is guided by the read mappings. Then, for each
precursor sequence, the secondary structure and the energetic
stability are predicted. Finally, the precursors are scored.
We identified 21 non-overlapping high-confidence
predictions. For each of these predictions, we determined
whether the 3p and/or the 5p mature microRNA has counts of
at least ten in three or more samples. While seven microRNAs
fulfilled this criterion, the remaining ones were discarded.
In the course of this study, we name these 7 microRNAs
novel_1-5p, novel_3-3p, novel_4-5p, novel_12-5p, novel_18-5p,
novel_20-3p, and novel_21-3p. Five of them (novel_3-3p,
novel_12-5p, novel_18-5p, novel_20-3p, and novel_21-3p) are
located in introns of protein coding genes, where novel_3-3p
and novel_21-3p are on the opposite strand of the respective
genes. The pri-microRNA of novel_20-3p, however, also overlaps
with an exon of gene WDFY4. Novel_4-5p is located in an
intergenic area and novel_1-5p lies within the 3′-UTR of gene
DDX58 (Table 4 and Supplementary Table 3). Of the seven
predicted novel microRNAs, three could be validated by qPCR
experiments in independent samples. These are novel_3-3p,
novel_4-5p, and novel_12-5p (Figure 5 and Supplementary
Table 4). We then used BLAST to compare the sequences of
these three microRNAs to the known sequences from miRBase
(Supplementary Table 5). The BLAST results revealed a high
similarity of novel_3-3p to the sequences of the miR-378 family.
Therefore, we performed a multiple sequence alignment using
ClustalW to determine which of the miR-378 microRNAs is most
closely related to novel_3-3p. The resulting phylogenetic tree
visualizes the relations between the sequences (Figure 6). The
microRNA miR-378j has the smallest distance to novel_3-3p,
indicating highest similarity. Another hint for a close relation
to miR-378j is the fact that this microRNA is the only member
of the miR-378 family, which has no mismatch in the seed
sequence compared to novel_3-3p (Figure 7). The microRNAs
of the miR-378 family play a role in rhabdomyosarcoma,
myogenesis, and apoptosis (Knezevic et al., 2012; Megiorni et al.,
2014).
The BLAST results further indicate a connection between
miR-1260a/b and novel_4-5p. They share the same seed
sequence and, except for one mismatch, the first 15 nt are
identical at lengths of 18-19 nt (Figure 7). While miR-1260a
was shown to be up-regulated in patients with pelvic organ
prolapse (Jeon et al., 2015), miR-1260b plays a role in kidney
cancer (Hirata et al., 2013). The seed sequence of novel_12-
5p seems to be unique among the known microRNAs and
also the BLAST results did not yield any major sequence
similarities.
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FIGURE 3 | Experimental analysis of predicted microRNA-target-interactions by silencing of the microRNAs (A,B) miR-132-5p and (C–F) miR-212-5p
using siRNA. Target gene expression was measured with quantitative real-time PCR. We observed a trend toward up-regulation for the target genes, although this
regulation is not statistically significant. The infection with C. albicans led to a stronger up-regulation than the infection with A. fumigatus (ns = random non-silencing
control siRNA sample).
4. DISCUSSION
In this study, we present the analysis of the regulatory response
of microRNAs of human DCs in reaction to fungal infection
and LPS treatment. As a first step, we identified the DEMs
for each condition. When visualizing the expression patterns
of the DEMs by an MDS (Figure 2) plot, we made two major
observations. First, we found that the samples of the fungal
species are mixed and are clearly separated from the LPS samples.
This finding indicates a similar microRNA regulation in the anti-
fungal response. Moreover, this response seems to be specific and
different from the reaction to LPS. This indicates that microRNAs
might be used as biomarkers discriminating fungal from bacterial
infections which is often crucial for treatment decisions in clinical
settings. Second, we discovered that for all conditions the 6 h
samples were more closely related to the controls than the 12 h
samples. This suggests that the regulation in consequence of the
treatment was stronger after 12 h than after 6 h. One possible
reason for this observation is that microRNA expression has to
be induced by a trigger event, which in this study is the treatment
with a fungus or LPS. This induction may not be completed after
6 h and thus more microRNAs are up-regulated at 12 h. Both
of the above mentioned findings can be confirmed by the Venn
diagrams (Figure 1), showing overlaps of the DEMs for the three
conditions. In these diagrams, we found that the overall numbers
of DEMs are smaller for 6 h compared to 12 h. Second, two peaks
in the DEM numbers can be found for both time points: for LPS
only as well as for A. fumigatus and C. albicans together.
The analysis of differential expression revealed similar
regulatory patterns for the 3p and the 5p mature microRNA
of both mir-132 and mir-212 after 12 h of stimulation. These
two microRNAs are relatively closely located in the genome and
member of the miR-132/212 cluster. In addition, miR-132-3p
and miR-212-3p share the same seed sequence and thus may
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FIGURE 4 | Further indication for microRNA-target-interactions were collected via western blots and silencing of the microRNAs (A) miR-132-5p and
(B–D) miR-212-5p. Similarly to the PCR experiments, the up-regulation of the predicted target genes is not statistically significant, but a trend toward up-regulation
can be found. The up-regulation is stronger for the A. fumigatus infection compared to the C. albicans infection.
TABLE 4 | The genomic locations of the mature, precursor, and primary sequences of the validated novel microRNAs.
Name Chromosome Strand Mature Precursor Primary
Start End Start End Start End
novel_3-3p chr12 + 29715552 29715573 29715503 29715573 29715482 29715591
novel_4-5p chr6 − 10662281 10662298 10662236 10662298 10662211 10662318
novel_12-5p chr19 + 52303197 52303219 52303197 52303258 52303177 52303288
have many common target genes. In our study, we obtained a
similar list of target genes for these two microRNAs (Tables 2,
3). The regulatory patterns of the miR-132/212 cluster suggest
a strong involvement of these microRNAs in the anti-fungal
response. However, the data also indicated that they are of
no major importance for the response to LPS. It has been
reported that miR-132-3p and miR-212-3p are involved into
the neuron morphogenesis, are down-regulated in several brain-
related disorders, and also play a role in regulating immune
processes (Wanet et al., 2012). Moreover, Das Gupta et al. (2014)
showed an up-regulation of miR-132-3p in DCs in response to
A. fumigatus stimulation, whereas a stimulation with LPS had
no effect on miR-132-3p. These observations are in accordance
with our results, which supports the assumption of a regulatory
function specific to fungal infections.
As shown in many studies, microRNAs may also serve as
biomarkers (Keller et al., 2011; Rupani et al., 2013; Keller et al.,
2014; Dix et al., 2015). Their presence/absence or their expression
levels can indicate particular conditions of the organism. These
associations can be used to improve the diagnosis of a disease
or to better predict the prognosis of it. As indicated by out data
as well as by the results from Das Gupta et al. (2014), miR-132-
3p may be considered as a novel biomarker candidate. Based on
data from our study, microRNA profiling might be applied to
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FIGURE 5 | Hairpin structures of the three experimentally validated novel microRNAs. The sequences of the mature microRNAs that were predicted by
miRDeep2 are shown in red.
FIGURE 6 | The phylogenetic tree of the members of the miR-378 family. The tree was generated by ClustalW and shows the relations between the microRNAs
based on their sequences. It indicates that the newly discovered microRNA novel_3-3p is closest related to miR-378j.
the diagnosis of other pathogenic fungi or infectious diseases.
However, follow-up experiments are required to assess the quality
of the presented microRNAs as biomarkers in experiments with a
larger sample size and a broader range of fungal infection studies.
We used different tools to determine the target genes of
the fungal-specific microRNAs and filtered these lists based
on inverse regulation and correlation.The number of predicted
target genes is much higher than the number of validated target
genes. A reason is that bioinformatic target prediction tools yield
high amounts of false positive results, since microRNAs are very
short. Additionally, the number of validated targets is closely
connected to the factor of how well studied a microRNA is.
Validation experiments are usually performed for microRNAs
that are relevant for a study, which therefore leads to a bias
in the number of verified MTIs. In the presented results, the
most immunological relevant target genes were identified for
the microRNAs miR-132-5p and miR-212-5p. These microRNAs
are not yet known to be of immunological significance. We
performed experiments to validate the predicted interactions
with these immune-relevant genes. Although no statistical
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FIGURE 7 | Alignment of the novel microRNAs (A) novel_3-3p with the
members of the miR-378 family and (B) novel_4-5p with miR-1260a/b. The
alignment was created with ClustalW.
significance could be found for the expression changes of the
selected target genes after microRNA silencing, a trend of
up-regulation among these genes was observed. However, the
regulatory patterns of the PCR experiments and the western
blots are contrary for A. fumigatus and C. albicans. This finding
indicates a considerable influence of post-transcriptional and/or
translational regulation as well as of the different stabilities of
RNA and proteins. Indeed, it has been reported that the squared
Pearson correlation of mRNA and protein levels is only at ≈0.4
(Vogel and Marcotte, 2012). The small extend of up-regulation
suggests that the microRNAs perform a fine-tuning of the gene
expression and other gene regulatory mechanisms, for example
transcription factors, seem to play a larger role for the anti-
fungal immune response in DCs. Nevertheless, fine regulatory
mechanisms are important for controlling immune processes
(Gantier et al., 2007). For example, studies have shown that
microRNAs fine-tune the TLR4 signaling and the sensitivity of
T cell during their differentiation (Sonkoly et al., 2008; O’Neill
et al., 2011).
Although our validation experiments are limited in their
extent, we could identify and verify miR-132-5p and miR-212-5p
as regulators in DCs during fungal infections. To demonstrate the
relevance of miR132-5p and miR212-5p in additional immune
cell populations, experiments stimulating human primary natural
killer (NK) cells with A. fumigatus, followed by subsequent
microRNA extraction and qPCR-based quantification ofmiR132-
5p and miR212-5p expression were performed. While expression
of miR132-5p did significantly change in NK cells stimulated
with A. fumigatus, expression of miR212-5p was significantly
increased after 6 h of co-cultivation (p= 0.036). This observation
indicates the general relevance of miR212-5p in various cell
populations of the innate immunity. In addition, our previous
work shows that in human primarymonocytesmiR-132 (and also
miR-155) was differentially expressed after stimulation with A.
fumigatus. Interestingly, miR-132 was induced by the fungus but
not by LPS in this cell type (Das Gupta et al., 2014). Furthermore,
Wanet et al. (2012) reported that miR-212 and miR-132 are
expressed in various immune cells, like macrophages, mast cells
and lymphatic endothelial cells. However, it remains an open task
for future studies to shed light on the role of these microRNAs
in other tissues and under different conditions. Also, an analysis
of a broader range of microRNA regulations would be of great
value.
Beside the analysis of the known microRNAs, we predicted
previously undiscovered microRNAs. Three novel microRNAs
were experimentally confirmed. The sequence similarities of
novel_3-3p to the members of the miR-378 family strongly
suggest that we found a new microRNA of this family. In
addition, we discovered a striking resemblance of novel_4-5p to
themicroRNAsmiR-1260a/b. For this reason, we strongly believe
that the newly identified novel_4-5p is closely related to these two
microRNAs. We hope that our discoveries may help the scientific
community to reveal new regulatory relationships in the field of
microRNA research.
In conclusion, this study provides new insights into the
regulatory role of microRNAs in DCs in response to fungal
infections by C. albicans and A. fumigatus. We identified
expression patterns that are common for both fungal pathogens
and are different from LPS treatment. We performed validation
experiments of microRNAs and their predicted target genes
revealing fine-tuning regulations by miR-132-5p and miR-212-
5p in anti-fungal immune response. Moreover, we successfully
discovered and experimentally verified novel microRNAs. While
two of them are probably strongly related to known microRNAs,
the third one represents a completely new microRNA species.
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